Developing strategies for prevention and treatment of recurrent HBV in liver transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):485-6. doi: 10.1016/s0041-1345(98)01720-5.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • 2-Aminopurine / analogs & derivatives*
  • 2-Aminopurine / economics
  • 2-Aminopurine / therapeutic use
  • Adult
  • Aged
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Costs and Cost Analysis
  • Famciclovir
  • Florida
  • Follow-Up Studies
  • Hepatitis B / diagnosis
  • Hepatitis B / prevention & control
  • Hepatitis B / surgery*
  • Hepatitis B / therapy*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / isolation & purification
  • Humans
  • Immunization, Passive* / economics
  • Immunoglobulins / economics
  • Lamivudine / economics
  • Lamivudine / therapeutic use*
  • Liver Transplantation*
  • Middle Aged
  • Postoperative Complications
  • Recurrence
  • Time Factors

Substances

  • Antiviral Agents
  • Immunoglobulins
  • Lamivudine
  • 2-Aminopurine
  • Famciclovir
  • hepatitis B hyperimmune globulin